Brief: Maat Pharma Increases Resources Allocated To Liquidity Contract With Kepler Cheuvreux
Oct 9 (Reuters) - Maat Pharma SA MAAT.PA :
* INCREASE IN RESOURCES ALLOCATED TO THE LIQUIDITY CONTRACT
WITH
THE BROKERAGE FIRM KEPLER CHEUVREUX
* AN ADDITIONAL CONTRIBUTION OF 50,000 EUROS WAS MADE ON
OCTOBER
6TH, 2023, UNDER THE LIQUIDITY CONTRACT IMPLEMENTED SINCE MARCH
22, 2022
* UPDATED RESOURCES ALLOCATED TO THE LIQUIDITY ACCOUNT ARE
EUR
250,000
Source text for Eikon: urn:newsml:reuters.com:*:nBw5rvy6ta
Further company coverage: MAAT.PA
(Gdansk Newsroom)
((gdansknewsroom@thomsonreuters.com; + 48 58 7785110;))
Recent news on Maat Pharma SA
See all newsBrief: MaaT Pharma Says FDA Indicates No Additional Nonclinical Studies Required For MaaT034 Safety
France's MaaT Pharma H1 operating loss widens on higher R&D costs
Brief: MaaT Pharma SA Receives 'Negative Trend' Opinion For Upcoming June CHMP Vote For MaaT013 (Xervyteg)
France's MaaT Pharma 2025 revenue rises 40.7% but misses expectations
Brief: MaaT Pharma Says Xervyteg Under EMA Review, Decision Expected In H2 2026